
HIV 1 group M subtype B (isolate PCV12) Protein Nef 73-82, QVPLRPMTYK
Description
About HIV 1 group M subtype B (isolate PCV12) Protein Nef 73-82, QVPLRPMTYK
The Human immunodeficiency virus (HIV) type 1 group M subtype B (isolate PCV12) Nef protein (NEF) Peptide (IEDB: 52760) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Nef protein (NEF) Peptide, H-QVPLRPMTYK-OH (Uniprot: P04324 aa: 73-82) from JPT is produced under strict quality control and quality management.
HIV 1 group M subtype B (isolate PCV12) Protein Nef 73-82, QVPLRPMTYK - Specifications
- Peptide sequence: H-QVPLRPMTYK-OH
- Amount: 1 mg
- Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
- Counterion: TFA
- Delivery Format: Freeze-dried in glass vial
- Application(s): T-cell Immunity
- Condition(s)/Topic(s): AIDS (HIV)
- Standard Delivery Time: approx. 3 weeks
JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Peptide Synthesis Services!
Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!
References
References for HIV 1 group M subtype B (isolate PCV12) Protein Nef 73-82, QVPLRPMTYK
References:
Read References with JPT’s Antigen Peptides
HIV 1 group M subtype B (isolate PCV12) Protein Nef 73-82, QVPLRPMTYK has been described in:
Extensive HLA class I allele promiscuity among viral CTL epitopes., Eur J Immunol, 2007 (PMID: 17705138)
Altered ex vivo balance between CD28+ and CD28- cells within HIV-specific CD8+ T cells of HIV-seropositive patients., Eur J Immunol, 1999 (PMID: 9933084)
Revisiting the arthritogenic peptide theory: quantitative not qualitative changes in the peptide repertoire of HLA-B27 allotypes., Arthritis Rheumatol, 2015 (PMID: 25418920)
Documentation
Documentation for HIV 1 group M subtype B (isolate PCV12) Protein Nef 73-82, QVPLRPMTYK
Properties
Properties of HIV 1 group M subtype B (isolate PCV12) Protein Nef 73-82, QVPLRPMTYK
Properties | Values |
---|---|
Application: | T-cell immunity |
Category: | Antigen Peptides |
Condition / Topic: | AIDS (HIV) |
Layout: | Freeze-dried in glass vial |
Organism: | Human immunodeficiency virus (HIV) |
Protein Name: | Nef protein (NEF) |
Purity: | Trial Grade: each peptide purified to > 90% (HPLC/MS) |
Quantification: | No, Yes |
Further Information to HIV 1 group M subtype B (isolate PCV12) Protein Nef 73-82, QVPLRPMTYK
Information | Values |
---|---|
Sequence: | H-QVPLRPMTYK-OH |
Specifications: | 10mer peptide as TFA salt |